Related references
Note: Only part of the references are listed.
Article
Biochemistry & Molecular Biology
Wanwisa Dejnirattisai et al.
Summary: On November 24, 2021, the sequence of a new SARS-CoV-2 variant, Omicron-B.1.1.529, was announced. Compared to previous variants, Omicron has a higher number of mutations in the Spike (S) protein. Serum neutralization of Omicron by individuals vaccinated or previously infected with Alpha, Beta, Gamma, or Delta variants is significantly reduced or ineffective. Third vaccine doses can boost neutralization titers against Omicron, and high titers are observed in both vaccinated individuals and those infected with the Delta variant. Most potent monoclonal antibodies and antibodies under development are unable to effectively neutralize Omicron due to mutations in its Spike protein. Omicron has structural changes compared to earlier viruses and utilizes mutations that enhance its binding to ACE2, allowing for immune escape. This results in a large number of mutations in the ACE2 binding site and a rebalancing of receptor affinity similar to earlier pandemic viruses.
Article
Biochemistry & Molecular Biology
Pengcheng Han et al.
Summary: The study found that the omicron variant, unlike other variants, has a similar affinity to the human receptor ACE2 as the prototype variant. Multiple mutations in the omicron variant may compensate for both immune escape and transmissibility. The complex structures of the omicron and delta variants binding to ACE2 provide insights into how specific mutations affect the binding.
Article
Multidisciplinary Sciences
Delphine Planas et al.
Summary: The Omicron variant of SARS-CoV-2, identified in November 2021, has spread rapidly worldwide and shows resistance to most therapeutic monoclonal antibodies and vaccine-elicited antibodies. However, it can be neutralized by antibodies generated by a booster vaccine dose.
Article
Multidisciplinary Sciences
Elisabetta Cameroni et al.
Summary: The Omicron variant of SARS-CoV-2 has raised concerns due to its 37 amino acid substitutions in the spike protein, particularly in the receptor-binding domain (RBD), leading to increased binding affinity with human ACE2. Neutralizing activity against Omicron was greatly reduced in convalescent and vaccinated individuals compared to the ancestral virus, but this decrease was less significant after a third vaccine dose. Broadly neutralizing monoclonal antibodies recognizing conserved RBD epitopes may be crucial in combating the Omicron variant and future zoonotic transmissions.
Article
Multidisciplinary Sciences
Kang Wang et al.
Summary: The Omicron variant of SARS-CoV-2 is highly resistant to neutralizing antibodies, which raises concerns about the effectiveness of antibody therapies and vaccines. A study found that individuals who received two or three doses of an inactivated SARS-CoV-2 vaccine had varying rates of seroconversion for neutralizing antibodies. The effectiveness of neutralizing antibodies against Omicron was significantly lower in individuals who received three vaccine doses. However, monoclonal antibodies derived from individuals who received three vaccine doses showed strong neutralizing activity against all variants of concern, including Omicron.
Article
Multidisciplinary Sciences
Yunlong Cao et al.
Summary: The Omicron variant of SARS-CoV-2 contains 15 mutations in the receptor-binding domain, leading to evasion of over 85% of tested neutralizing antibodies. Different epitope groups of neutralizing antibodies are affected to varying degrees by single mutations of Omicron. Antibodies targeting the conserved region of sarbecovirus remain most effective against Omicron.
Article
Multidisciplinary Sciences
Lihong Liu et al.
Summary: The B.1.1.529/Omicron variant of SARS-CoV-2, initially detected in southern Africa, has rapidly spread globally and is expected to become dominant due to its enhanced transmissibility in the coming weeks. This variant poses a threat to the efficacy of current COVID-19 vaccines and antibody therapies due to its significant antibody resistance. Even individuals who have received vaccines and booster doses may have reduced neutralizing activity against B.1.1.529.
Article
Multidisciplinary Sciences
Dhiraj Mannar et al.
Summary: The newly reported Omicron variant shows new salt bridges and hydrogen bonds formed by mutated residues in the receptor binding domain, compensating for reduced ACE2 binding affinity. It also exhibits increased antibody evasion, which likely contributes to its rapid spread.
Article
Multidisciplinary Sciences
Wanchao Yin et al.
Summary: The structures of the Omicron spike trimer and its interactions with ACE2 and an anti-Omicron antibody are reported. Most mutations in Omicron are located on the spike protein surface, altering binding to many existing antibodies. Compensating mutations in the ACE2-binding site enhance binding to ACE2. The therapeutic antibody JMB2002 maintains neutralizing activity against Omicron and inhibits ACE2 binding.
Article
Microbiology
Ziwei Yang et al.
Summary: The variants of concern of SARS-CoV-2 have mutations that enhance transmission and reduce the effectiveness of COVID-19 vaccines and treatments. These variants have a higher propensity to bind to the human receptor and exhibit slower transitions between receptor-bound states. These findings provide insights into the adaptation strategies of SARS-CoV-2.
Review
Microbiology
Anshumali Mittal et al.
Summary: This review focuses on the emerging SARS-CoV-2 variants, the structural basis for antibody-mediated neutralization, and the identification of escape mutations for designing escape-resistant antibody therapeutics and vaccines.
Article
Immunology
Masaud Shah et al.
Summary: The new SARS-CoV-2 variant Omicron has enhanced transmissibility and multiple mutations that may weaken the effectiveness of therapeutic antibodies. Computational studies have shown that Omicron binds to ACE2 with a higher strength and specific mutations contribute significantly to the binding energies. These mutations also result in a drop in the electrostatic potential between RBDOmic and monoclonal antibodies, particularly etesevimab, bamlanivimab, and CT-p59. Sotrovimab, which targets a conserved epitope on the Spike protein, could be used as a cocktail therapy for Omicron-driven COVID-19.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Cheng Li et al.
Summary: This study identifies two highly conserved regions on the Omicron variant receptor-binding domain that are recognized by broadly neutralizing antibodies, and generates a bispecific antibody that can simultaneously bind these regions, showing excellent therapeutic efficacy and neutralization breadth.
Article
Microbiology
Jingwen Ai et al.
Summary: This study compared the neutralization efficacy of vaccine-induced or monoclonal antibodies against different sub-lineages of the Omicron variant. The results showed that current vaccines have low neutralization activity, but both homologous and heterologous boosters significantly improved neutralization titers. The study also found that most monoclonal antibodies lost their neutralizing activity, while some demonstrated distinct neutralization patterns among Omicron sub-lineages, indicating antigenic differences.
CELL HOST & MICROBE
(2022)
Article
Biology
Olaposi Omotuyi et al.
Summary: This study investigates the interaction between the Omicron variant and ACE2 receptor and neutralizing monoclonal antibodies. The results show that Omicron has evolved into an efficient ACE2 binder but has become less efficient in binding neutralizing antibodies.
COMPUTERS IN BIOLOGY AND MEDICINE
(2022)
Article
Biochemistry & Molecular Biology
Gennady Verkhivker et al.
Summary: In this study, all-atom MD simulations and comprehensive mutational scanning were used to investigate the interactions between SARS-CoV-2 variants and the ACE2 host receptor. It was found that specific mutations in the Omicron variant play a crucial role in virus transmissibility and immune evasion. Furthermore, other mutations provide a flexible shield to protect the integrity of binding and allosteric interactions in the RBD-ACE2 complexes.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Chemistry, Medicinal
Gennady M. Verkhivker et al.
Summary: The D614G mutation in the spike protein of SARS-CoV-2 variants plays an important role in enhancing virus infectivity and transmissibility. By studying the dynamics of multiple substates of the D614G spike trimers, this research reveals patterns of mutational sensitivity in functional regions and sites and proposes a mechanism of allosteric regulation through conformational flexibility and energetic frustration at the interprotomer interfaces.
JOURNAL OF CHEMICAL INFORMATION AND MODELING
(2022)
Article
Biochemistry & Molecular Biology
Sophie M-C Gobeil et al.
Summary: The SARS-CoV-2 Omicron variant, aided by extensive spike protein mutation, has surpassed the previously dominant Delta variant. Cryo-EM structures of the Omicron and Delta spikes reveal the conformational impacts of mutations, with the Omicron spike showing a tightly packed RBD organization and increased flexibility at the fusion peptide site.
Article
Multidisciplinary Sciences
Qin Hong et al.
Summary: This study used cryo-electron microscopy to reveal the structural features of the Omicron variant spike protein and its interactions with the ACE2 receptor and antibodies, providing important insights for further research and design of vaccines targeting this variant.
Article
Biochemistry & Molecular Biology
Shawn M. Costello et al.
Summary: HDX-MS analysis reveals a reversible open-trimer conformation in the SARS-CoV-2 spike ectodomain, which exposes epitopes for pan-coronavirus antibody. The interconversion between this conformation and the prefusion structure is regulated by temperature, ACE2 receptor binding, and sequence variants. Understanding the structure and populations of this conformation is crucial for improving diagnostics, therapeutics, and vaccines.
NATURE STRUCTURAL & MOLECULAR BIOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Damiano Clementel et al.
Summary: Residue interaction networks (RINs) have been proven effective in analyzing complex systems as an alternative to coordinate data. The new RING 3.0 version extends the previous functionality by supporting mmCIF format, providing typed interactions for the entire PDB chemical component dictionary, and employing probabilistic graphs for analyzing structural data. The web interface has also been expanded to enhance visualization and interactivity.
NUCLEIC ACIDS RESEARCH
(2022)
Article
Multidisciplinary Sciences
Magnus S. Bauer et al.
Summary: This study introduces a new assay that can quantitate the interaction between SARS-CoV-2 and ACE2 under mechanical load. Through experimental and simulation approaches, the researchers provide important insights into the RBD:ACE2 interaction, which is crucial for understanding the infection mechanism of SARS-CoV-2 and developing targeted pharmaceutical interventions.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Multidisciplinary Sciences
Matthew McCallum et al.
Summary: The SARS-CoV-2 Omicron variant evades antibody-mediated immunity and exhibits enhanced affinity for host cells due to accumulation of spike mutations and remodeling of interactions with the ACE2 receptor.
Article
Multidisciplinary Sciences
Tongqing Zhou et al.
Summary: In this study, the cryo-electron microscopy structures of the B.1.1.529 (Omicron) variant of SARS-CoV-2 were determined, and receptor binding domain (RBD) antibodies were evaluated for their ability to bind and neutralize this variant. The study found that certain monoclonal antibodies still retained substantial inhibitory activity and identified combinations of antibodies with synergistic neutralization.
Review
Virology
Annick Barre et al.
Summary: The spread of SARS-CoV-2 variants depends on the interaction between the electropositive spike protein RBD and the electronegative ACE2 receptor. Point mutations that increase electropositive residues, such as arginine and lysine, in the RBD of spike proteins can enhance recognition by the electronegative ACE2 receptors and contribute to the spreading capacity of the variants. Highly transmissible variants like kappa, delta, and omicron have an enhanced electropositive character in their RBDs due to a higher number of lysine or arginine-generating point mutations.
Article
Virology
Harry Ridgway et al.
Summary: SARS-CoV-2 virus rapidly evolves due to mutations in the receptor-binding domain, enabling tighter binding to ACE2 and accelerating infection. Non-RBD and non-interfacial mutations also assist S-protein in adopting favorable conformations for stronger binding.
Article
Microbiology
Nash D. Rochman et al.
Summary: This study analyzed the impact of receptor-binding domain mutations in the SARS-CoV-2 virus and its Delta, Gamma, and Omicron variants on the risk of antibody escape. The results suggest that although Omicron poses new evolutionary risks compared to Delta, structural constraints on the receptor-binding domain make continued evolution towards more complete vaccine escape unlikely.
Article
Biology
Marco A. Diaz-Salinas et al.
Summary: This study reveals the effects of ACE2 and antibody binding on the conformational dynamics of SARS-CoV-2 spike protein. The D614G mutation and antibodies targeting diverse epitopes are found to modulate the energetics of the receptor-binding domain (RBD) position and enhance ACE2 binding. These findings offer insights into the development of therapeutic antibody cocktails.
Article
Biology
Hisham M. Dokainish et al.
Summary: The Spike protein plays a crucial role in neutralization and vaccine development for SARS-CoV-2. Its inherent flexibility provides essential information for designing antiviral drugs and vaccines.
Article
Immunology
Ian W. Windsor et al.
Summary: Neutralizing antibodies against SARS-CoV-2 spike glycoprotein have different potencies and escape resistance. Antibodies binding to the ACE2 binding surface have the highest neutralization potency but are most sensitive to viral escape, while antibodies binding to two other epitopic regions have lower potency but broader coverage.
SCIENCE IMMUNOLOGY
(2022)
Article
Immunology
Wenjuan Du et al.
Summary: The emergence of the Omicron variant, resulting from the ongoing evolution of SARS-CoV-2, poses a challenge due to its immune escape potential. However, a receptor-blocking human monoclonal antibody, 87G7, has been identified to retain potent neutralizing activity against various SARS-CoV-2 variants, including Omicron. It targets a conserved region in the ACE2-binding site, explaining its broad neutralization capacity. In animal models, 87G7 demonstrated both prophylactic and therapeutic efficacy against SARS-CoV-2 challenges. This finding suggests that 87G7 holds promise as a resilient prophylactic or therapeutic agent for COVID-19.
SCIENCE IMMUNOLOGY
(2022)
Review
Virology
Dibya Ghimire et al.
Summary: The global pandemic of COVID-19 caused by SARS-CoV-2 has greatly impacted human lives and overwhelmed the healthcare system worldwide. The emergence of SARS-CoV-2 variants, especially variants of concern (VOCs), along with limited therapeutic options, has prolonged the pandemic and posed challenges for its control. The Spike (S) protein on the virus surface plays a crucial role in virus entry and is the target of current vaccines. However, the high mutability of S protein can affect virus-host interactions. Scientists have rapidly studied the atomic structures of VOCs and mutations, providing insights for the development of therapeutics and vaccines. This article discusses recent findings on transmissibility and immune evasion of SARS-CoV-2 VOCs and highlights the structural flexibility of S variants and the impact of mutations on its functions.
Letter
Cell Biology
Lei Wang et al.
Article
Virology
Hin Hark Gan et al.
Summary: High transmissibility is a characteristic of the Omicron variant of SARS-CoV-2. The electrostatic properties of the Spike protein play a role in enhancing ACE2 recognition and evading antibodies. The findings suggest that electrostatic interactions contribute to the increased transmissibility of the Omicron variant.
FRONTIERS IN VIROLOGY
(2022)
Letter
Cell Biology
Jun Lan et al.
Article
Chemistry, Physical
Md Lokman Hossen et al.
Summary: In this study, we computationally examined the impact of omicron RBD mutations on its structure and interactions with surrounding domains in the spike trimer as well as with ACE2. Our findings suggest that these mutations facilitate a more efficient RBD down to up conformation and ACE2 attachment compared to WT and delta, which, along with antibody evasion, may contribute to omicron's dominance over delta.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS
(2022)
Article
Immunology
Wenjuan Du et al.
Summary: The study identified a human monoclonal antibody, 87G7, with broad neutralizing activity against various SARS-CoV-2 variants, showing promise as a prophylactic or therapeutic agent for COVID-19.
SCIENCE IMMUNOLOGY
(2022)
Article
Immunology
Ian W. Windsor et al.
SCIENCE IMMUNOLOGY
(2022)
Article
Multidisciplinary Sciences
Jessica A. Plante et al.
Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.
Article
Biophysics
Takaharu Mori et al.
Summary: This study conducted molecular dynamics simulations on glycosylated S-proteins to investigate conformational stability and transition mechanisms. Key determinants of stability in each form were found to be N-glycans and interacting residues, while electrostatic interactions and hydrogen bonds drove the conformational transitions.
BIOPHYSICAL JOURNAL
(2021)
Article
Chemistry, Physical
Gennady M. Verkhivker et al.
Summary: This study investigated the molecular mechanisms underlying conformational and dynamic changes in SARS-CoV-2 spike mutant trimers, revealing how mutations can differentially affect dynamics and allosteric signaling in distinct functional states. Key functional regions and regulatory centers that govern collective dynamics, allosteric interactions, and control signal transmission in the SARS-CoV-2 spike proteins were identified. The study also provided insights into allosteric regulatory mechanisms of SARS-CoV-2 spike proteins, proposing a plausible strategy for therapeutic intervention by targeting specific hotspots of allosteric interactions and communications.
JOURNAL OF PHYSICAL CHEMISTRY B
(2021)
Article
Multidisciplinary Sciences
Cong Xu et al.
Summary: The recent global health emergency caused by SARS-CoV-2 outbreak is mediated by the interaction between the SARS-CoV-2 trimeric spike glycoprotein and the human ACE2 receptor. The SARS-CoV-2 S trimer is more sensitive to ACE2 receptor compared to SARS-CoV S trimer, potentially contributing to its superior infectivity. Research findings depict the mechanism of ACE2-induced conformational transitions in S trimer structure, aiding in the development of anti-SARS-CoV-2 vaccines and therapeutics.
Article
Biochemistry & Molecular Biology
Wanwisa Dejnirattisai et al.
Summary: Antibodies play a crucial role in immune protection against SARS-CoV-2, with some being used as therapeutics. A study identified 377 human monoclonal antibodies, focusing on 80 that bind the virus spike, and found that most highly inhibitory antibodies can block the virus-receptor interaction. Novel binding modes of potent inhibitory antibodies were discovered, showing potential for prophylactic or therapeutic use in animal models.
Article
Biochemistry & Molecular Biology
Kamyab Javanmardi et al.
Summary: The Spike Display platform characterized 200 variant SARS-CoV-2 spikes, revealing a public epitope in the N-terminal domain loops that is recognized by most NTD-binding nAbs. Mutations in NTDs of variants like B.1.1.7, B.1.351, B.1.1.28, B.1.427/B.1.429, and B.1.617.2 impact spike expression and escape most NTD-targeting nAbs. Certain variants like B.1.351 and B.1.1.28 completely evade binding by a potent ACE2 mimic.
Article
Multidisciplinary Sciences
Dhiman Ray et al.
Summary: Researchers are focusing on the correlation between the RBD region of the SARS-CoV-2 virus and residues distant from it to understand molecular recognition events and predict key mutations for therapeutics. Their model can identify multiple residues with long-distance coupling with the RBD opening and successfully predict some key mutations.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Article
Multidisciplinary Sciences
Houriiyah Tegally et al.
Summary: The article describes a newly emerged lineage of SARS-CoV-2, 501Y.V2, characterized by eight mutations in the spike protein, which may result in increased transmissibility or immune escape. This lineage originated in South Africa and quickly became dominant in Eastern Cape, Western Cape, and KwaZuluNatal provinces within weeks.
Article
Biochemistry & Molecular Biology
Houriiyah Tegally et al.
Summary: The study identified 16 new lineages of SARS-CoV-2 in South Africa between March and August 2020, with unique mutations not found elsewhere. Three lineages (B.1.1.54, B.1.1.56, and C.1) dominated during the country's first wave, accounting for approximately 42% of all infections. The C.1 lineage, with 16 nucleotide mutations including the D614G spike protein change, became the most geographically widespread by August 2020. Genomic surveillance played a crucial role in identifying the 501Y.V2 variant in South Africa in December 2020.
Article
Multidisciplinary Sciences
Nicholas G. Davies et al.
Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.
Article
Multidisciplinary Sciences
Alexander Muik et al.
Summary: A new SARS-CoV-2 lineage B.1.1.7 has emerged in the UK, which is more transmissible and faster spreading than other strains. However, a study found that the BNT162b2 vaccine offers largely preserved protection against the B.1.1.7 lineage, despite some reduced neutralizing titers.
Article
Multidisciplinary Sciences
Melanie Koehler et al.
Summary: The study utilized atomic force microscopy and molecular dynamics to investigate the impact of SARS-CoV-2 variants on the kinetic, thermodynamic, and structural properties of RBD-ACE2 complex formation. The research found a significant increase in complex stability for several variants of concern.
NATURE COMMUNICATIONS
(2021)
Article
Genetics & Heredity
Chunyan Yi et al.
Summary: This study identified 33 amino acid positions within four independent antigenic sites of RBD as valuable indicators of antigenic changes. The research confirms widely circulating strains carrying important immune-escape RBD mutations, while also uncovering new immune escape-enabling mutations. Co-mutations may lead to increased resistance to NAbs and convalescent plasma, emphasizing the importance of monitoring the accumulation of co-mutations on distinct major antigenic sites.
Article
Biochemistry & Molecular Biology
Gennady M. Verkhivker et al.
Summary: This study identified key residues within the SARS-CoV-2 spike protein that play crucial roles in binding with ACE2 host receptor, and demonstrated their impact on long-range communication in complexes through allosteric interactions. The research suggests that mutational variants and antibody-escaping mutations tend to target structurally plastic and energetically adaptable centers to modulate interactions within the complexes.
Article
Biochemistry & Molecular Biology
Hin Hark Gan et al.
Summary: The study reveals that new variants of the SARS-CoV-2 Spike protein show enhanced binding affinity to the human ACE2 receptor, potentially increasing transmissibility. Structural analysis predicts variant combinations with both enhanced affinity and antibody resistance, highlighting the complexity of viral evolution and potential impact on intervention strategies.
JOURNAL OF MOLECULAR BIOLOGY
(2021)
Article
Chemistry, Physical
Gennady M. Verkhivker et al.
Summary: The study investigates the molecular mechanisms underlying the modulation of dynamics and allosteric signaling in the SARS-CoV-2 spike proteins induced by binding to antibodies using coevolutionary analysis, molecular simulations, and perturbation-based hierarchical network modeling. Through these methods, the study identifies highly coevolving hotspots and functional clusters that enable cross-talk between distant allosteric regions in the spike complexes with antibodies, demonstrating how antibodies can induce specific and functionally relevant changes in the spike proteins by modulating their allosteric propensities and collective dynamics. The findings provide insights into the regulatory mechanisms of SARS-CoV-2 spike proteins and how antibody-escaping mutations may target energy hotspots and allosteric effector centers to control functional movements and allosteric communication in the complexes.
JOURNAL OF PHYSICAL CHEMISTRY B
(2021)
Editorial Material
Multidisciplinary Sciences
Kevin D. McCormick et al.
Article
Biochemical Research Methods
Mateusz Sikora et al.
Summary: The spike protein of the SARS-CoV-2 virus plays a crucial role in infection and is the primary target for antibodies. Through molecular dynamics simulations and bioinformatics analyses, accessible epitopes have been identified for potential vaccine development. The extensive and flexible glycan coat covering the spike protein presents challenges in antibody binding but also reveals promising epitope candidates for structure-based vaccine design.
PLOS COMPUTATIONAL BIOLOGY
(2021)
Review
Immunology
Ling Niu et al.
Summary: This review summarizes the current understanding of the structural landscape of neutralizing antibodies targeting the RBD of SARS-CoV-2 spike glycoprotein. It discusses the potential impact of identifying sites of vulnerability and the formation of better vaccines and immunotherapeutics. The review also highlights the importance of additional analysis of vaccine-induced nAbs in the development of improved vaccines.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Multidisciplinary Sciences
Rachael A. Mansbach et al.
Summary: The emergence of the G-form variant of COVID-19 has led to a more infectious strain with increased viral loads, likely due to changes in protein energetics favoring infection-capable states and enhanced exposure of the receptor binding domain. These findings are crucial for vaccine design.
Article
Cell Biology
Wei Hu et al.
Summary: The spike protein of SARS-CoV-2 recognizes host receptors through mechanical force, accelerating viral entry and fusion. Mutations can strengthen viral binding and detachment speed, while certain antibodies derived from recovered patients show potential for therapeutic strategies.
Article
Chemistry, Medicinal
Gennady M. Verkhivker et al.
Summary: The computational framework developed in this study allows for comprehensive and rapid mutational scanning of binding energetics and residue interaction networks in the SARS-CoV-2 spike protein complexes. The research reveals the key regions of structural plasticity, mutational impact, and functional response, emphasizing the importance of dynamic crosstalk between binding affinities and structural stability with conformational adaptability for resilience.
JOURNAL OF CHEMICAL INFORMATION AND MODELING
(2021)
Article
Chemistry, Physical
Gennady Verkhivker et al.
Summary: The study investigates how SARS-CoV-2 spike proteins interact with different classes of antibodies through atomistic simulations and scanning approaches, revealing their functional adaptability and regulatory mechanisms. The research also explores how antibody binding modulates allosteric propensities of spike protein residues, identifying versatile allosteric centers targeted by circulating mutations that can elicit resistance to antibody binding.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION
(2021)
Article
Chemistry, Physical
Hung Nguyen et al.
Summary: Understanding the structure of how antibodies bind SARS-CoV-2 at an atomic level is crucial for developing more effective treatments for Covid-19. Using simulations, it was found that CR3022 has a higher affinity for the virus than 4A8, with electrostatic interactions playing a key role in this difference. This could guide the development of new antibodies with charged amino acids for combating Covid-19.
JOURNAL OF PHYSICAL CHEMISTRY B
(2021)
Article
Chemistry, Multidisciplinary
Lucy Fallon et al.
Summary: The SARS-CoV-2 coronavirus spike protein plays a crucial role in viral entry and is a target for neutralizing antibodies. By using simulations, interactions influencing spike protein dynamics can be identified for potential therapeutic targeting. Small molecules binding to specific pockets may modulate the spike protein equilibrium and shed light on its conformational changes.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
(2021)
Article
Multidisciplinary Sciences
M. Alejandra Tortorici et al.
Summary: The emergence of SARS-CoV-2 variants and recurrent spillovers of coronaviruses into the human population emphasize the need for broadly neutralizing antibodies to prevent future zoonotic infections. The human monoclonal antibody S2X259 has shown promising results in neutralizing various forms of SARS-CoV-2 and potentially zoonotic sarbecoviruses by inhibiting the binding of ACE2 to the receptor-binding domain. This antibody targets a key antigenic site and may guide the design of vaccines effective against all sarbecoviruses.
Article
Chemistry, Multidisciplinary
Maxwell Zimmerman et al.
Summary: Researchers utilized the Folding@home project to simulate the viral proteome of SARS-CoV-2 and discovered 'cryptic' epitopes, with spike variants affecting the balance between receptor binding and immune evasion. The data and models generated provide valuable insight for the design of antiviral drugs.
Article
Chemistry, Multidisciplinary
Terra Sztain et al.
Summary: Through simulations, the study reveals the mechanism of spike protein receptor binding domain (RBD) opening in SARS-CoV-2 infection, highlighting the crucial role of N-glycan in facilitating RBD opening. This research represents a milestone in ensemble pathway simulations and provides a foundation for understanding the fundamental mechanisms of viral entry and infection.
Article
Multidisciplinary Sciences
Lingshu Wang et al.
Summary: The study identified four receptor binding domain-targeting antibodies with potent neutralizing activity against 23 variants, including two ultrapotent antibodies. Combinations of these antibodies reduced the in vitro generation of escape mutants, showing potential in mitigating resistance development.
Article
Multidisciplinary Sciences
Kathryn M. Hastie et al.
Summary: Antibody-based therapeutics and vaccines are crucial in combating COVID-19, especially with mutations and transmission of SARS-CoV-2. An international consortium identified multiple RBD-directed antibody communities, providing a framework for selecting treatment cocktails.
Article
Microbiology
Marta Alenquer et al.
Summary: Understanding the evolution of SARS-CoV-2 and host immunity is crucial in controlling COVID-19 pandemics. Mutations in the spike protein can impact antibody and ACE2 binding, requiring monitoring of SARS-CoV-2 evolution and dynamics. Identifying signatures in SARS-CoV-2 that make the virus resistant to neutralizing antibodies is critical for the development of therapies, vaccines, and diagnostics.
Article
Biology
Michael Barton et al.
Summary: The study analyzed the effects of mutations in the Spike protein of SARS-CoV-2 on its interaction with ACE2, finding that most mutations increased affinity with ACE2. Two ACE2 mutations were also found to enhance binding with the Spike protein.
Article
Microbiology
Keng-Chang Tsai et al.
Summary: This study comprehensively investigated the mutational effects of RBD of SARS-CoV-2 on binding to neutralizing antibodies and ACE2. It identified certain residues consistent with clinically emerging variants or experimental observations. Common hotspots were also revealed to have comparable destabilizing effects on binding to both ACE2 and neutralizing antibodies.
FRONTIERS IN MICROBIOLOGY
(2021)
Article
Immunology
Ashlesha Deshpande et al.
Summary: This study investigated the impact of RBD mutations in SARS-CoV-2 on ACE2 and NAb binding, revealing that mutations such as K417T, E484K, and N501Y disrupted the binding of 65% of evaluated NAbs, indicating concern for the P.1 Japan/Brazil strain. Additionally, the L452R mutation enhanced ACE2 binding affinity while disrupting C1 and C2 NAb classes.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Immunology
Catherine A. Hogan et al.
Summary: This study evaluated the relative contribution of VOCs in nearly 67,000 infections in British Columbia during the first 16 weeks of 2021, finding that B.1.1.7, B.1.351, and P.1 showed different spreading patterns in the region. While B.1.1.7 and P.1 increased in proportion, P.1 expanded rapidly, while B.1.351 remained a minority.
EMERGING INFECTIOUS DISEASES
(2021)
Article
Multidisciplinary Sciences
Daniel Wrapp et al.
Article
Biochemistry & Molecular Biology
Qihui Wang et al.
Article
Biochemistry & Molecular Biology
Alexandra C. Walls et al.
Article
Immunology
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY
(2020)
Article
Multidisciplinary Sciences
Dora Pinto et al.
Article
Biochemistry & Molecular Biology
Bette Korber et al.
Article
Biochemistry & Molecular Biology
Rory Henderson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY
(2020)
Article
Biochemistry & Molecular Biology
Xiaoli Xiong et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY
(2020)
Article
Biochemistry & Molecular Biology
Matthew McCallum et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY
(2020)
Article
Multidisciplinary Sciences
Ching-Lin Hsieh et al.
Article
Multidisciplinary Sciences
Yongfei Cai et al.
Article
Biochemical Research Methods
Gennady M. Verkhivker
JOURNAL OF PROTEOME RESEARCH
(2020)
Article
Multidisciplinary Sciences
Donald J. Benton et al.
Article
Multidisciplinary Sciences
Beata Turonova et al.
Article
Multidisciplinary Sciences
M. Alejandra Tortorici et al.
Article
Chemistry, Multidisciplinary
Lorenzo Casalino et al.
ACS CENTRAL SCIENCE
(2020)
Article
Microbiology
Maolin Lu et al.
CELL HOST & MICROBE
(2020)
Article
Multidisciplinary Sciences
Yixuan J. Hou et al.
Article
Chemistry, Medicinal
Henrique S. Fernandes et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING
(2019)
Article
Biochemical Research Methods
Jing Huang et al.
Article
Biochemistry & Molecular Biology
Peter W. Rose et al.
NUCLEIC ACIDS RESEARCH
(2017)
Editorial Material
Infectious Diseases
Yuelong Shu et al.
Article
Chemistry, Physical
Michele Di Pierro et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION
(2015)
Article
Biology
Anna Vangone et al.
Article
Chemistry, Physical
Sophie Sacquin-Mora
MOLECULAR SIMULATION
(2014)
Article
Biochemistry & Molecular Biology
Yves Dehouck et al.
NUCLEIC ACIDS RESEARCH
(2013)
Article
Chemistry, Multidisciplinary
Anthony Bocahut et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
(2011)
Article
Biochemistry & Molecular Biology
Junsu Ko et al.
NUCLEIC ACIDS RESEARCH
(2011)
Article
Biophysics
M. S. Vijayabaskar et al.
BIOPHYSICAL JOURNAL
(2010)
Article
Biochemistry & Molecular Biology
M. L. Hekkelman et al.
NUCLEIC ACIDS RESEARCH
(2010)
Article
Biochemical Research Methods
Yves Dehouck et al.
Article
Chemistry, Physical
Ruslan L. Davidchack et al.
JOURNAL OF CHEMICAL PHYSICS
(2009)
Article
Multidisciplinary Sciences
Anurag Sethi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2009)
Article
Biochemistry & Molecular Biology
Georgii G. Krivov et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
(2009)
Article
Biochemistry & Molecular Biology
Sophie Sacquin-Mora et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
(2007)
Article
Biochemistry & Molecular Biology
Narcis Fernandez-Fuentes et al.
NUCLEIC ACIDS RESEARCH
(2006)
Article
Biophysics
S Sacquin-Mora et al.
BIOPHYSICAL JOURNAL
(2006)
Article
Biophysics
Y Dehouck et al.
BIOPHYSICAL JOURNAL
(2006)
Article
Biochemistry & Molecular Biology
Antonio del Sol et al.
MOLECULAR SYSTEMS BIOLOGY
(2006)
Review
Chemistry, Multidisciplinary
JC Phillips et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY
(2005)
Article
Biophysics
KV Brinda et al.
BIOPHYSICAL JOURNAL
(2005)
Article
Biochemical Research Methods
A Fiser et al.
